Tim Kutzkey, PhD

Tim Kutzkey, PhD

Position: Managing Partner

Tim Kutzkey, Ph.D., is a Managing Partner of The Column Group. Since joining the firm in 2007 he has contributed to the conception, formation, and management of more than a dozen portfolio companies. He currently serves as the Chairman of the Board of Directors of Neurona Therapeutics, Surrozen, and Nura Bio, all companies for which he had served previously as the founding CEO. In addition, Dr. Kutzkey is a member of the Board of Directors of Kallyope, Plexium, Cajal Neuroscience, Synthekine, Carmot, and Atavistik Bio. Formerly, he was the founding CEO of Peloton Therapeutics and the Chairman of the Board of Directors of Nurix Therapeutics. Prior to joining The Column Group, Dr. Kutzkey was a scientist at KAI Pharmaceuticals where he focused on the discovery and development of selective protein kinase C inhibitors. Before KAI, he worked at UC Berkeley as a graduate student and postdoc in the lab of Dr. Robert Tjian, completing his Ph.D. in 2005. Dr. Kutzkey was previously educated at Stanford University.

Board of Directors: Surrozen (Chairman), Neurona Therapeutics (Chairman), Nura Bio (Chairman), Carmot Therapeutics, Kallyope, Plexium, Synthekine, Cajal Neuroscience, Atavistik Bio

Scroll to Top